Reprocessed EP catheters recalled | TAVR outcomes for men & women | The evolving ECG market | Updated instructions | PE research

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 

By tracking sex-related differences after TAVR, researchers hope to refine patient selection strategies and optimize care for both men and women.

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 

No devices need to be returned or replaced, but the company did want to update their instructions for use. 

Grants from $50,000 to $750,000 will be awarded to pay for physician-led studies focused on PE care.

The Impella CP heart pump is being used more and more to treat cardiogenic shock, and the benefits are clear. For many older patients, however, the technology seem to fall short. 

AF Symposium 2026 in Boston included new data from some of the biggest names in electrophysiology. Johnson & Johnson MedTech, Abbott, Atraverse Medical, Field Medical, Pulse Biosciences, Argá Medtech SA and CardioFocus were just some of the medtech companies at the heart of late-breaking presentations. 

HRS has shared an updated guidance on managing Boston Scientific defibrillation leads at risk of experiencing a significant malfunction. The issue, first reported in July 2025, is believed to impact approximately 350,000 leads still being used today.

The diet, named after the traditional eating habits of Greece and Italy, is already known for its benefits to the general public. Its impact on heart patients, however, was less clear. 

Mount Sinai Hospital in New York is now using AI-powered virtual agents to call some patients before cath lab procedures. The move was designed to help nurses focus more on patient care and reduce their risk of burnout.

Atherectomy is associated with rising healthcare costs, making it important to learn as much about the procedure's long-term value as possible. 

In a new poll, more insured adults listed receiving coverage approval for treatment and medications as the single largest burden they face when navigating the U.S. healthcare system than any other issue. KFF found that 47% experienced “denied, delayed or altered” patient care over the last two years. 

Someday the computerization of medicine will be recognized as the game-changing, paradigm-shifting, everything-upending “disruptive innovation” that so many healthcare watchers and stakeholders have been waiting for. “Today,” however, “it’s often just plain disruptive.”